IFNA1 and myasthenia gravis: Supporting evidence includes detection of neuromuscular antigens like AChRs, germinal centers, elevated Tfh cell counts in the thymus, changes in microRNAs, and specific IFN signaling in thymic epithelial cell subpopulations in MG patients with thymoma (34, 35).